HK, S., V, G., A, Z., M, G., M, C., VK, K., . . . LS, M. (2026). Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL. Blood, 147(17), 2011. https://doi.org/10.1182/blood.2025031734
Chicago Style (17th ed.) CitationHK, Srinagesh, et al. "Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene Autoleucel in B-cell ALL." Blood 147, no. 17 (2026): 2011. https://doi.org/10.1182/blood.2025031734.
MLA (9th ed.) CitationHK, Srinagesh, et al. "Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene Autoleucel in B-cell ALL." Blood, vol. 147, no. 17, 2026, p. 2011, https://doi.org/10.1182/blood.2025031734.
Warning: These citations may not always be 100% accurate.
